When the amendments to the Medicines and Related Substances Act come into operation, it will result in significant changes to the regulatory regime currently in place. According to guidelines issued by the department of health and Medicines Control Council (MCC), the new regulations will apply to the manufacturing, importing, exporting and distribution of medium- and..
Continue reading…